News

Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, today..

Impact Biomedical Inc. Announces Acquisition of Celios®, “Protecting People, Plants, and Animals from the World’s Most Dangerous Pathogens With Clean-Room..

Impact Biomedical Inc. today announced that Frank D. Heuszel, Chief Executive Officer, is pleased to announce his participation in The..

We closed our first quarter as a publicly traded company and wanted to address all current and future stakeholders highlighting..